sábado, 10 de septiembre de 2016

Breaking News: Parkinson’s Vaccine Study Shows Promising Results


Parkinson's Disease | Vaccine for Parkinson's Reports Positive Results from Boost Study

Vaccine Against Key Parkinson's Target Reports Positive Booster Study Results

New study results support the continued development of a vaccine against the key Parkinson's protein alpha-synuclein. Researchers hope this therapy may slow or stop disease progression.

The "booster" follow-up study, led by Austrian biotech AFFiRiS and funded by The Michael J. Fox Foundation, built on a positive Phase I clinical trial and allowed researchers to learn more about the potential application of this vaccine and its safety.

BUTTON_READ_MORE
The Michael J. Fox Foundation
Grand Central Station, P.O. Box 4777
New York, NY 10163-4777
1-800-708-7644
 


No hay comentarios:

Publicar un comentario